Coating Module Supports Easy Module Exchange

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-07-02-2017
Volume 41
Issue 7
Pages: 12

Tablet coating from DISONA can handle batch sizes up to 3 kg.

The new tablet coating module for the Minilab XP from DIOSNA supports easy module exchange, without the need for disassembling. The module is available for batch sizes from 500 g up to 3 kg. The module is equipped with a glass lid for process observation. Both modules are operated by a full graphical display, which allows for a change between manual and automatic modes. 

DIOSNA

 

 

Download Issue PDF
Articles in this issue
Packaging Improves Medication Adherence
Packaging Improves Medication Adherence
The New World of Biopharmaceutical Manufacturing
The New World of Biopharmaceutical Manufacturing
Forty Years of Drug Product Manufacturing Advances
Forty Years of Drug Product Manufacturing Advances
PT0717_Cover_200.jpg
Evolution of Dosage-Form Development and Manufacturing Strategies
Advances in Analytical Testing Tools for the Bio/Pharma Industry
Advances in Analytical Testing Tools for the Bio/Pharma Industry
PT0717_spotlignt_Ross_42N-36S.jpg
Ribbon Blenders for Specialty Applications
PT0717_spotlight_doisna_MiniCoater.jpg
Coating Module Supports Easy Module Exchange
PT0717_ProdSpotlight_distek.jpg
Dissolution Tester Eliminates Water Bath
PT0717_spotlight_sartorius_biostat_str_500.jpg
Bioreactor Family Includes Single-Use Bags
FDA Continues to Promote Quality Drug Production
FDA Continues to Promote Quality Drug Production
A 30-Year History of PLG Applications in Parenteral Controlled Drug Release
A 30-Year History of PLG Applications in Parenteral Controlled Drug Release
Coatings Sweeten Pharma Tablet Production
Coatings Sweeten Pharma Tablet Production
PT0717_Cover_200-6.jpg
Continuous API Manufacturing
PT0717_OSD_fig3Innopharma_250.jpg
Moving Toward Real-Time Release Testing
PT0717_Cover_200-8.jpg
Advances in ADCs
Recent Videos
Behind the Headlines episode 6
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Alentis Therapeutics to Advance Anti-Claudin-1 ADCs to Treat Solid Tumors on $181.4 Million Financing

Feliza Mirasol
November 19th 2024
Article

Financing from OrbiMed, Novo Holdings, Jeito Capital, and others will enable Alentis Therapeutics to advance its pipeline of Claudin-1-targeted ADCs for treating solid tumors.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Newly Opened Innovation Center in New Jersey Gives Avantor Advantage in Solving Life Sciences Challenges

Feliza Mirasol
November 15th 2024
Article

Avantor's newly launched expanded Innovation Center in Bridgewater, NJ, is designed for integrated workflows and features purpose-built collaboration spaces.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Merck and Ginkgo Bioworks’ Collaboration to Improve Biologics Manufacturing Has Reached Its First Milestone

Feliza Mirasol
November 13th 2024
Article

Under an ongoing partnership with Merck, known as MSD outside of the United States and Canada, Ginkgo Bioworks has achieved the first milestone in a project aimed at improving biologics production.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

TrakCel’s OCELLOS Platform Selected to Support Treatment Management of Five Upcoming Cell Therapy Products

Feliza Mirasol
November 13th 2024
Article

Manufacturers of five autologous or matched allogenic cell therapy products have selected TrakCel's IT platform, OCELLOS, to orchestrate the administration of these therapies, which are approved or expected to be approved in 2024.